BRENTUXIMAB VEDOTIN CONSOLIDATION AFTER AUTOLOGOUS STEM CELLS TRANSPLANTATION FOR HODGKIN LYMPHOMA: A REAL‐LIFE EXPERIENCE BY FONDAZIONE ITALIANA LINFOMI (FIL)
- Resource Type
- Source
- Hematological Oncology. 39
- Subject
Oncology Cancer Research medicine.medical_specialty business.industry Hematology General Medicine Transplantation Internal medicine medicine Hodgkin lymphoma Stem cell Brentuximab vedotin business medicine.drug - Language
- ISSN
- 1099-1069
0278-0232